Vimarsana
Biggest News Aggregation in the World

Page 2 - Wall St Engine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wall St Engine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wall St Engine Today - Breaking & Trending Today

Toyota Was Dubbed a Doddering Octogenarian When It Refused To Budge Toward EVs and Now Its Dealers Just Captured 29 Percent of the Industry's Total New Car Gross Margin - Vimarsana News

Toyota Was Dubbed a Doddering Octogenarian When It Refused To Budge Toward EVs and Now Its Dealers Just Captured 29 Percent of the Industry's Total New Car Gross Margin

Toyota is thriving right now with its hybrids-first strategy, while its competitors, including Tesla, face a challenging demand environment.

Novo Nordisk's GLP-1 Weight Loss Drug Wegovy Is Not a Panacea for Obesity - Vimarsana News

Novo Nordisk's GLP-1 Weight Loss Drug Wegovy Is Not a Panacea for Obesity

Novo Nordisk's Wegovy GLP-1 offering is increasingly looking like a stepping stone instead of the promised panacea for the obesity pandemic. 

Xiaomi beats Apple, first EV hitting the roads this month - Vimarsana News

Xiaomi beats Apple, first EV hitting the roads this month

ALBAWABA – Chinese smartphone manufacturer and fifth largest in the republic, Xiaomi, has announced that deliveries will start for its first and highly

One of the Biggest Tesla Bulls Now Sees the Stock Potentially Plunging by Another 40 Percent to the $100 Price Level - Vimarsana News

One of the Biggest Tesla Bulls Now Sees the Stock Potentially Plunging by Another 40 Percent to the $100 Price Level

Morgan Stanley's Adam , Jonas said in today's morning call that Tesla's "$100 bear case" is now in play over the next few months.

Cutting-Edge Biotech: A Novel Gene Therapy That Reverses Aging and a New Oral GLP-1 Drug From Viking Therapeutics - Vimarsana News

Cutting-Edge Biotech: A Novel Gene Therapy That Reverses Aging and a New Oral GLP-1 Drug From Viking Therapeutics

Viking Therapeutics' GLP-1 drug is able to induce an average weight loss of 14.7% of the body weight after just 13 weeks of treatment.